Report Detail
Global and United States Radiopharmaceuticals in Nuclear Medical Market Insights, Forecast to 2026
- RnM4191297 |
- 07 September, 2020 |
- Global |
- 144 Pages |
- QYResearch |
- Medical Devices & Consumables
Radiopharmaceuticals in Nuclear Medical market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Radiopharmaceuticals in Nuclear Medical market is segmented into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Segment by Application, the Radiopharmaceuticals in Nuclear Medical market is segmented into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial
Regional and Country-level Analysis
The Radiopharmaceuticals in Nuclear Medical market is analysed and market size information is provided by regions (countries).
The key regions covered in the Radiopharmaceuticals in Nuclear Medical market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Radiopharmaceuticals in Nuclear Medical Market Share Analysis
Radiopharmaceuticals in Nuclear Medical market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Radiopharmaceuticals in Nuclear Medical business, the date to enter into the Radiopharmaceuticals in Nuclear Medical market, Radiopharmaceuticals in Nuclear Medical product introduction, recent developments, etc.
The major vendors covered:
Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Medtronic
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
1 Study Coverage
- 1.1 Radiopharmaceuticals in Nuclear Medical Product Introduction
- 1.2 Market Segments
- 1.3 Key Radiopharmaceuticals in Nuclear Medical Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Type
- 1.4.2 Diagnostic Radiopharmaceuticals
- 1.4.3 Therapy Radiopharmaceuticals
- 1.4.4 Enriched Stable Isotopes
- 1.5 Market by Application
- 1.5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Application
- 1.5.2 Diagnostic Application
- 1.5.3 Therapeutic Application
- 1.5.4 Research
- 1.5.5 Pharmaceutical
- 1.5.6 Industrial
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size, Estimates and Forecasts
- 2.1.1 Global Radiopharmaceuticals in Nuclear Medical Revenue 2015-2026
- 2.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales 2015-2026
- 2.2 Global Radiopharmaceuticals in Nuclear Medical, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Radiopharmaceuticals in Nuclear Medical Historical Market Size by Region (2015-2020)
- 2.3.1 Global Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Radiopharmaceuticals in Nuclear Medical Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Radiopharmaceuticals in Nuclear Medical Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (2021-2026)
- 2.4.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2021-2026)
3 Global Radiopharmaceuticals in Nuclear Medical Competitor Landscape by Players
- 3.1 Global Top Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers
- 3.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers (2015-2020)
- 3.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue
- 3.2.1 Global Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Radiopharmaceuticals in Nuclear Medical Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medical Revenue in 2019
- 3.2.5 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Radiopharmaceuticals in Nuclear Medical Price by Manufacturers
- 3.4 Global Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution, Product Types
- 3.4.1 Radiopharmaceuticals in Nuclear Medical Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
- 3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type (2015-2020)
- 4.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2015-2020)
- 4.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2015-2020)
- 4.1.3 Radiopharmaceuticals in Nuclear Medical Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2021-2026)
- 4.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026)
- 4.2.3 Radiopharmaceuticals in Nuclear Medical Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Application (2015-2020)
- 5.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2015-2020)
- 5.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Application (2015-2020)
- 5.1.3 Radiopharmaceuticals in Nuclear Medical Price by Application (2015-2020)
- 5.2 Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2021-2026)
- 5.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
- 6.1 United States Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2015-2026
- 6.1.1 United States Radiopharmaceuticals in Nuclear Medical Sales YoY Growth 2015-2026
- 6.1.2 United States Radiopharmaceuticals in Nuclear Medical Revenue YoY Growth 2015-2026
- 6.1.3 United States Radiopharmaceuticals in Nuclear Medical Market Share in Global Market 2015-2026
- 6.2 United States Radiopharmaceuticals in Nuclear Medical Market Size by Players (International and Local Players)
- 6.2.1 United States Top Radiopharmaceuticals in Nuclear Medical Players by Sales (2015-2020)
- 6.2.2 United States Top Radiopharmaceuticals in Nuclear Medical Players by Revenue (2015-2020)
- 6.3 United States Radiopharmaceuticals in Nuclear Medical Historic Market Review by Type (2015-2020)
- 6.3.1 United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2015-2020)
- 6.3.2 United States Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2015-2020)
- 6.3.3 United States Radiopharmaceuticals in Nuclear Medical Price by Type (2015-2020)
- 6.4 United States Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 United States Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2021-2026)
- 6.4.2 United States Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026)
- 6.4.3 United States Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2021-2026)
- 6.5 United States Radiopharmaceuticals in Nuclear Medical Historic Market Review by Application (2015-2020)
- 6.5.1 United States Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2015-2020)
- 6.5.2 United States Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2015-2020)
- 6.5.3 United States Radiopharmaceuticals in Nuclear Medical Price by Application (2015-2020)
- 6.6 United States Radiopharmaceuticals in Nuclear Medical Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 United States Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2021-2026)
- 6.6.2 United States Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2021-2026)
- 6.6.3 United States Radiopharmaceuticals in Nuclear Medical Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2015-2026
- 7.2 North America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
- 7.2.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Country (2015-2020)
- 7.2.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2015-2026
- 8.2 Europe Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
- 8.2.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Country
- 8.2.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
- 9.2.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2015-2026
- 10.2 Latin America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
- 10.2.1 Latin America Radiopharmaceuticals in Nuclear Medical Sales by Country
- 10.2.2 Latin America Radiopharmaceuticals in Nuclear Medical Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Country
- 11.2.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Bracco Imaging
- 12.1.1 Bracco Imaging Corporation Information
- 12.1.2 Bracco Imaging Description and Business Overview
- 12.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.1.5 Bracco Imaging Recent Development
- 12.2 Cambridge Isotope Laboratories
- 12.2.1 Cambridge Isotope Laboratories Corporation Information
- 12.2.2 Cambridge Isotope Laboratories Description and Business Overview
- 12.2.3 Cambridge Isotope Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.2.5 Cambridge Isotope Laboratories Recent Development
- 12.3 Cardinal Health
- 12.3.1 Cardinal Health Corporation Information
- 12.3.2 Cardinal Health Description and Business Overview
- 12.3.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.3.5 Cardinal Health Recent Development
- 12.4 Medtronic
- 12.4.1 Medtronic Corporation Information
- 12.4.2 Medtronic Description and Business Overview
- 12.4.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.4.5 Medtronic Recent Development
- 12.5 Eczacibasi-Monrol
- 12.5.1 Eczacibasi-Monrol Corporation Information
- 12.5.2 Eczacibasi-Monrol Description and Business Overview
- 12.5.3 Eczacibasi-Monrol Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.5.5 Eczacibasi-Monrol Recent Development
- 12.6 Fujifilm Holdings Corporation
- 12.6.1 Fujifilm Holdings Corporation Corporation Information
- 12.6.2 Fujifilm Holdings Corporation Description and Business Overview
- 12.6.3 Fujifilm Holdings Corporation Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.6.5 Fujifilm Holdings Corporation Recent Development
- 12.7 GE Healthcare (Subsidiary Of General Electric Company)
- 12.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
- 12.7.2 GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
- 12.7.3 GE Healthcare (Subsidiary Of General Electric Company) Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
- 12.8 IBA Group
- 12.8.1 IBA Group Corporation Information
- 12.8.2 IBA Group Description and Business Overview
- 12.8.3 IBA Group Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.8.5 IBA Group Recent Development
- 12.9 Lantheus Medical Imaging
- 12.9.1 Lantheus Medical Imaging Corporation Information
- 12.9.2 Lantheus Medical Imaging Description and Business Overview
- 12.9.3 Lantheus Medical Imaging Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.9.5 Lantheus Medical Imaging Recent Development
- 12.10 Nordion
- 12.10.1 Nordion Corporation Information
- 12.10.2 Nordion Description and Business Overview
- 12.10.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.10.5 Nordion Recent Development
- 12.11 Bracco Imaging
- 12.11.1 Bracco Imaging Corporation Information
- 12.11.2 Bracco Imaging Description and Business Overview
- 12.11.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
- 12.11.5 Bracco Imaging Recent Development
- 12.12 Siemens Healthcare
- 12.12.1 Siemens Healthcare Corporation Information
- 12.12.2 Siemens Healthcare Description and Business Overview
- 12.12.3 Siemens Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 12.12.4 Siemens Healthcare Products Offered
- 12.12.5 Siemens Healthcare Recent Development
- 12.13 Taiyo Nippon Sanso Corporation
- 12.13.1 Taiyo Nippon Sanso Corporation Corporation Information
- 12.13.2 Taiyo Nippon Sanso Corporation Description and Business Overview
- 12.13.3 Taiyo Nippon Sanso Corporation Sales, Revenue and Gross Margin (2015-2020)
- 12.13.4 Taiyo Nippon Sanso Corporation Products Offered
- 12.13.5 Taiyo Nippon Sanso Corporation Recent Development
- 12.14 Urenco Limited
- 12.14.1 Urenco Limited Corporation Information
- 12.14.2 Urenco Limited Description and Business Overview
- 12.14.3 Urenco Limited Sales, Revenue and Gross Margin (2015-2020)
- 12.14.4 Urenco Limited Products Offered
- 12.14.5 Urenco Limited Recent Development
- 12.15 Rotem Industries
- 12.15.1 Rotem Industries Corporation Information
- 12.15.2 Rotem Industries Description and Business Overview
- 12.15.3 Rotem Industries Sales, Revenue and Gross Margin (2015-2020)
- 12.15.4 Rotem Industries Products Offered
- 12.15.5 Rotem Industries Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medical Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Radiopharmaceuticals in Nuclear Medical Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Radiopharmaceuticals in Nuclear Medical. Industry analysis & Market Report on Radiopharmaceuticals in Nuclear Medical is a syndicated market report, published as Global and United States Radiopharmaceuticals in Nuclear Medical Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Radiopharmaceuticals in Nuclear Medical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
